Freshfields Bruckhaus Deringer and CMS Cameron McKenna have advised on the largest European private equity deal since before the global financial crisis, worth €9.6bn (£8.4bn).

The two law firms have advised as Japanese pharma company Takeda makes a move into the European market with the debt-free purchase of Swiss-based drug-maker Nycomed from its private equity owners.